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Abstract 
Background: RNA:DNA hybrids represent a non-canonical nucleic acid structure that has been associated with a 
range of human diseases and potential transcriptional regulatory functions. Mapping of RNA:DNA hybrids in human 
cells reveals them to have a number of characteristics that give insights into their functions.
Results: We find RNA:DNA hybrids to occupy millions of base pairs in the human genome. A directional sequenc-
ing approach shows the RNA component of the RNA:DNA hybrid to be purine-rich, indicating a thermodynamic 
contribution to their in vivo stability. The RNA:DNA hybrids are enriched at loci with decreased DNA methylation 
and increased DNase hypersensitivity, and within larger domains with characteristics of heterochromatin formation, 
indicating potential transcriptional regulatory properties. Mass spectrometry studies of chromatin at RNA:DNA hybrids 
shows the presence of the ILF2 and ILF3 transcription factors, supporting a model of certain transcription factors 
binding preferentially to the RNA:DNA conformation.
Conclusions: Overall, there is little to indicate a dependence for RNA:DNA hybrids forming co-transcriptionally, with 
results from the ribosomal DNA repeat unit instead supporting the intriguing model of RNA generating these struc-
tures in trans. The results of the study indicate heterogeneous functions of these genomic elements and new insights 
into their formation and stability in vivo.
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Background
The complex regulatory process leading to gene expres-
sion involves, as a major upstream influence, the effects 
of transcription factors (TFs) binding to specific DNA 
motifs. The targeting of TFs to specific locations is an 
informational puzzle, as the number of potential binding 
sites represented by their generally short sequence bind-
ing motifs vastly exceeds the minority used in vivo. This 
observation suggests that there is additional informa-
tion present in genomic organization that determines 
the selection of this subset of sequence motifs. Studies 
aiming to identify these extra layers of genomic informa-
tion have revealed influences of chromatin organization 
[1–4] and DNA methylation [4–6], each of which can 
facilitate or reduce TF binding to cognate motifs, but the 
role of the conformation of the DNA molecule in vivo is 
less well studied. While it is known that nucleic acids can 
form numerous non-canonical conformations [7], the 
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influence of these conformations in living cells remains 
under-studied. There is, however, evidence from in vitro 
assays that DNA conformation influences binding of pro-
teins [8]. As examples, the SP1 transcription factor binds 
preferentially to the intra-strand G-quadruplex struc-
ture in vitro [9], while we have found the methyl-binding 
domain of the Mecp2 protein to bind preferentially to 
single-stranded DNA (ssDNA), also in  vitro [10]. These 
observations indicate that the exploration of these and 
other non-canonical structures occurring in  vivo may 
be fruitful in adding a layer of information to the tran-
scriptional regulatory processes. The potential for ssDNA 
to occur in living cells, prompted by the results of our 
Mecp2 studies [10], raised the question about how such 
structures could be created and maintained stably in vivo. 
One candidate process to mediate the stable formation of 
ssDNA is the generation of an RNA:DNA hybrid on one 
DNA strand leaving the other strand in a single-stranded 
conformation, a nucleic acid structure referred to as an 
R-loop [11].
Formation of an R-loop has multiple potential con-
sequences in terms of local organization of transcrip-
tional regulatory elements. The helical conformation of 
the RNA:DNA hybrid differs from the B-form typical 
of double-stranded DNA (dsDNA), instead creating a 
conformation intermediate with the A-form associated 
with dsRNA [12]. A locus forming an RNA:DNA hybrid 
therefore creates a double-stranded A/B intermediate 
conformation, with a second target for single-stranded 
nucleic acid binding proteins on the complementary, 
displaced DNA strand. Another property of the R-loop 
is the displacement by the RNA of G-rich ssDNA [13, 
14], allowing the formation of intramolecular G-quad-
ruplex structures [15]. The potential that RNA:DNA 
hybrids may be resistant to the activity of DNA meth-
yltransferases has previously been proposed [16], as has 
their failure to organize DNA into a nucleosomal con-
formation [17], further adding to their local influence on 
nucleic acid organization.
Formation and maintenance of an RNA:DNA hybrid is 
subject to many influences [13, 14, 18–21]. Transcription 
of a locus has been positively associated with RNA:DNA 
hybrid formation [22, 23], presumably by the RNA act-
ing in cis with the DNA from which it was transcribed, 
but there is evidence in yeast that Rad51 can facilitate 
RNA molecules in trans also forming RNA:DNA hybrids 
[24]. Mutations of enzymes such as RNase H [25], which 
specifically hydrolyzes the RNA in RNA:DNA hybrids, 
RNA helicases [26] and topoisomerases [27] have been 
found to be associated with the increased formation of 
RNA:DNA hybrids, supporting a model in which these 
enzymes normally function to remove these structures 
from the genome. The presence of RNA:DNA hybrids at 
ribosomal DNA repeats appears to be a conserved fea-
ture from yeast [28] to human cells [16], for which any 
associated physiological role remains unclear. Function-
ally, RNA:DNA hybrids and their associated ssDNA 
regions have been found to have numerous properties 
in vitro and in vivo in a range of organisms. These include 
involvement in immunoglobulin class switching [29, 30], 
regulation of gene expression [31], constitutive formation 
in yeast telomeres [32] and at the origin of replication 
in mitochondrial DNA [21]. Additionally, these struc-
tures have been linked with epigenetic modifications, 
such as chromatin organization through enrichment at 
condensed chromatin marked by histone H3 serine 10 
(H3S10) phosphorylation in yeast, C. elegans and human 
HeLa cells [33], centromeric heterochromatin [34], and 
formation at promoter CpG islands lacking DNA methyl-
ation [16]. The functions attributed to RNA:DNA hybrids 
are thus diverse and appear to have a major degree of 
dependence upon their genomic context.
RNA:DNA hybrids are being increasingly associated 
with human diseases, with a major concern that their 
presence predisposes a locus to chromosomal breakage. 
For example, it has been shown that R-loops are pro-
cessed by the nucleotide excision repair endonucleases 
XPF and XPG into double strand breaks [35], and both 
BRCA1 [36] and BRCA2 [37] have been implicated as 
major processing enzymes involved in the resolution of 
RNA:DNA hybrids. The formation of RNA:DNA hybrids 
has also been associated with a number of neurological 
diseases. Mutations in the RNA:DNA helicase senataxin 
(SETX) mutations are implicated in the dominant juve-
nile form of amyotrophic lateral sclerosis type 4 (ALS4) 
and a recessive form of ataxia oculomotor apraxia type 
2 (AOA2) [38]. RNase H2 (RNASEH2) mutations are 
among those associated with Aicardi-Goutières syn-
drome, in which the accumulation of unusual nucleic 
acids triggers inflammatory and autoimmune responses 
[39]. In addition, it is known that triplet repeats are prone 
to forming unusual nucleic acid structures, including 
R-loops and RNA:DNA hybrids, a phenomenon con-
served in organisms from prokaryotes [40] to mamma-
lian cells [22]. Trinucleotide repeat expansion diseases 
are therefore being evaluated for a potential contribu-
tion of nucleic acid structures to disease pathogenesis, 
with accumulating evidence that R-loops are involved in 
Fragile X syndrome [22, 41, 42] and Friedreich’s ataxia 
[42], with similar events also occurring in hexanucleotide 
repeat expansions [43]. We refer the reader to a number 
of excellent recent reviews of this topic for more com-
plete insights into these unusual nucleic acid structures 
and their disease associations [11, 44, 45].
To establish a foundation for understanding their func-
tion, we mapped RNA:DNA hybrids genome-wide in vivo 
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in two human cell lines with parallel transcriptional and 
proteomic studies. These studies provide new insights 
into how specific loci are preferentially selected as sites 
of formation of these structures, and allow the infer-
ence of some of their likely functional properties. These 
non-canonical nucleic acid structures occur in ribosomal 
DNA and at tens of thousands of loci in the remainder 
of the genome, with sequence characteristics indicat-
ing a polypurine-richness of the RNA in the hybrid that 
is likely to increase the thermodynamic stability of these 
structures. RNA:DNA hybrids appear to have heteroge-
neous and context-dependent properties, with subgroups 
showing relationships with local transcription and chro-
matin structural features, and a general trend towards 
decreased DNA methylation. On a more regional scale of 
hundreds of kilobases, RNA:DNA hybrids are enriched 
in regions of the genome with a greater abundance of L1 
LINEs and CpG islands, and the chromatin modifications 
indicative of heterochromatin organization. These find-
ings also support the possibility that the RNA generating 
these RNA:DNA hybrids is frequently generated in trans, 
a set of results that combines to provide new insights into 




We optimized an assay previously published as 
DNA:RNA immunoprecipitation (DRIP) [16] to map 
RNA:DNA hybrids, changing several components of the 
protocol. These updates include the pre-treatment of 
the cellular nucleic acid with RNase I, the use of sonica-
tion with the goal of minimizing bias in fragmenting the 
nucleic acid, and the addition of directional information 
about the strand derived from the RNA component of 
the hybrid. Given the extensive changes made, we dis-
tinguish the updated assay with the new acronym RDIP 
(RNA:DNA immunoprecipitation). The assay is based 
on the use of the S9.6 antibody, which is believed to rec-
ognize the intermediate A/B helical RNA:DNA duplex 
conformation, with little to no sequence specificity [46]. 
We performed extensive in vitro testing of the antibody 
to reconfirm these properties, including electrophoretic 
mobility shift assays and South-Western blots of oligo-
nucleotides (including RNase H pre-treatment) that con-
firmed the necessary RNA:DNA hybrid specificity of the 
antibody (Additional file 1: Figure S1a–e).
The in  vivo studies were focused on the primary, 
non-transformed, diploid IMR-90 lung fibroblast cell 
line because of the substantial genome-wide data avail-
able from the Roadmap Epigenomics Program [47]. 
For comparison, we isolated a clone of HEK 293T cells 
that we found to have the least copy number variability 
of several tested as determined by array comparative 
genomic hybridization (Additional file 1: Figure S1f ). The 
immunoprecipitation using sonicated whole cell nucleic 
acid, pre-treated with RNase I, was optimized, and tested 
using a Southern dot blot using a (TTAGGG)n probe to 
confirm enrichment of the telomeric TERRA-associated 
R-loop [32] (Additional file 1: Figure S1g). This pre-treat-
ment with RNase I was recently shown to be necessary 
to reduce noise due to the S9.6 antibody detecting RNA 
in unusual conformations [48]. To allow the immunopre-
cipitated RNA:DNA hybrid to be ligated into sequenc-
ing adapters, an approach derived from RNA-seq library 
preparation was used. This provided the opportunity 
to introduce dUTP during second strand synthesis to 
reveal directional information about the strand on which 
the RNA molecule was located [49]. To confirm the 
RDIP-seq assay worked, we used peak calling analyti-
cal methodologies borrowed from ChIP-seq to identify 
the locations of RNA:DNA hybrids, followed by the use 
of single locus quantitative PCR to confirm enrichment 
in the immunoprecipitated material at these loci (Addi-
tional file 1: Figure S1h). Peaks were also verified at fur-
ther loci using the orthogonal approach of bisulphite 
sequencing of non-denatured DNA to demonstrate the 
presence of the ssDNA that occurs at R-loops [50] (Addi-
tional file 1: Figure S1i).
Subcellular localization studies
The subcellular localization of RNA:DNA hybrids has 
been studied in multiple organisms using a number of 
techniques [16, 24, 37, 51] and was investigated in the 
current study using two separate approaches. The first 
used limited amplification of the HEK 293T RDIP-seq 
library with a PCR primer to which the Texas Red fluoro-
phore had been conjugated. This was hybridized to con-
trol human metaphases for visualization. As early results 
suggested that the pericentromeric region of chromo-
some 9 was generating signal, a locus-specific probe 
targeting the subtelomeric region of the p arm of this 
specific chromosome was included in the fluorescence 
in  situ hybridization (FISH) study. Figure 1a depicts the 
results of these studies. A strong signal at the centromere 
of chromosome 9 is observed, as well as from the p arms 
of the acrocentric chromosomes, indicating enrichment 
at the Nucleolar Organising Regions (NORs), where ribo-
somal DNA (rDNA) repetitive sequences are located.
The second subcellular localization approach employed 
was to use the S9.6 antibody for immunofluorescence of 
the HEK 293T cells. Consistent with previously published 
studies [16, 52], a subnuclear enrichment within nucleoli 
(confirmed with an anti-fibrillarin antibody, Fig. 1b) was 
observed. Of note was the additional cytoplasmic signal 
that has also been noted in prior studies [52]. This signal 
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may in part reflect signals from mitochondrial DNA [53] 
or the S9.6 antibody detecting ssRNA in unusual confor-
mations [48].
Ribosomal DNA studies
Prompted by the co-localization with the NORs seen in 
the subcellular localization studies, further investiga-
tion into RNA:DNA hybrid formation within ribosomal 
DNA was undertaken. The IMR-90 RDIP library was 
sequenced and mapped to a human reference genome 
including the consensus ribosomal DNA repeat unit [54] 
(accession number gi|555853|gb|U13369.1|HSU13369), 
following the same approach as Zentner and colleagues 
[55]. The results showed that  ~2  % of reads mapped to 
the ribosomal DNA repeat unit and the remainder to the 
sequenced majority of the human genome. The mapping 
of reads to the rDNA repeat unit is shown in Fig. 2. The 
immunoprecipitated RNA:DNA hybrids map hetero-
geneously within this repeat unit, with accumulation of 
reads at the known exons of the rDNA gene, and others 
in the intergenic spacer (IGS) region.
To determine the relationship between the RNA:DNA 
hybrids and the transcribed sequences, RNA-seq on 
total RNA from the IMR-90 cells was performed with-
out polyA selection or depletion of ribosomal RNA. 
This allowed deep sequencing of the expressed rRNA 
and co-localization with the RNA:DNA hybrid reads 
(Fig.  2). The RDIP-seq reads in the 5′ end of the repeat 
unit are precisely co-localized with the RNA-seq reads, 
but there is RNA:DNA hybrid formation with compara-
ble read enrichment in the IGS region. Using K562 cell 
ChIP-seq data provided by Zentner and colleagues [55], 
the RNA:DNA hybrids are found to be located upstream 
from the rDNA promoter and flanking the candidate cis-
regulatory sequence in the IGS region (Fig. 2). The inter-
genic candidate cis-regulatory sequence was also shown 
to occur in embryonic stem cells, umbilical vein cells and 
normal human epidermal keratinocytes [55], and thus 
appears to be constitutive. It is therefore reasonable to 
predict that the element is also present in the IMR-90 
cells. Some of the rDNA RDIP-seq signal is attributable 
to RNA:DNA hybrid formation involving the canoni-
cal rRNA transcript, but further RNA:DNA hybrids are 
formed in the IGS ribosomal DNA region sparing the 
regions containing candidate cis-regulatory elements.
Genome‑wide studies
Having defined the source of the rDNA signal, the focus 
turned to the majority of reads that mapped to the 
remainder of the sequenced genome. There are tens of 
Fig. 1 Subcellular localization studies. In panel a we show the results of hybridization of the fluorescently-labeled RDIP-seq library to a control 
male metaphase preparation. The RDIP-seq library is shown in red, a bacterial artificial chromosome (BAC) probe mapping to chromosome 9 in 
green, and DNA counterstained by DAPI in blue. We observe a specific strong signal from the RDIP-seq library mapping to the p arms of acrocentric 
chromosomes (HSA13-15 and HSA21-22), indicating enrichment at the nucleolar organizing regions (NORs) encoding ribosomal RNAs, and at the 
pericentromeric region of chromosome 9. In panel b we show the results of immunofluorescence using the S9.6 antibody (green) with an antibody 
to fibrillarin (red), demonstrating co-localization with the intranuclear S9.6 antibody signal (merge) and therefore enrichment in nucleoli. Further 
signal from the nuclear periphery and the cytoplasm using S9.6 is also observed, which may represent detection by this antibody of RNA conforma-
tions rather than RNA:DNA hybrids specifically [48]
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thousands of RNA:DNA hybrid-forming loci (mapped 
as peaks using a ChIP-seq analytical approach) through-
out the human genome (Additional file  1: Figure S2), 
the same magnitude observed previously in DRIP-seq 
experiments [16]. There is a significant enrichment for 
loci shared by IMR-90 and HEK 293T cells, indicating 
that many RNA:DNA hybrid-forming loci may be con-
stitutive across cell types. Focusing on the loci in the 
human diploid IMR-90 fibroblast cell line, RNA:DNA 
hybrids are demonstrated to be distributed genome-
wide, with most of the peaks located in intergenic 
regions (Fig.  3a). The enrichment of peaks in each of 
these major genomic contexts was calculated and the 
significance of enrichment was tested based on over-
lap (nucleotide occupancy) using permutation analyses. 
Figure  3b shows that promoters (and the highly cor-
related CpG island feature) are strongly enriched for 
RNA:DNA hybrids, and that they are distributed else-
where in the genome at close to expected frequencies, 
apart from a modest but significant depletion at RefSeq 
gene bodies and intergenic regions (excluding promoter 
and lncRNA sequences).
As RNA:DNA hybrids in yeast have been shown to 
be enriched at transposons [28], their representation 
within sequences annotated as repetitive within the 
human genome was explored. In Fig.  3b, the sequences 
annotated as low complexity and simple repeats by 
RepeatMasker are shown to be the most strongly over-
represented, but satellite repeats are also found to be 
enriched in RNA:DNA hybrids. When the low complex-
ity repeats were explored in greater detail, the strand on 
which the RNA component of the RNA:DNA hybrid was 
located was found to be composed of GA-rich, G-rich, 
and A-rich families of low complexity repeats. Addition-
ally, within the satellite repeats that co-localized with the 
RNA of RNA:DNA hybrids, 76.5  % of the repeats were 
(GAATG)n sequences.
It is known that purine-rich RNA binds in  vitro with 
greater affinity to its pyrimidine-rich DNA comple-
ment than the equivalent purine-rich DNA sequence 
[12, 20], which may indicate a role for biochemical sta-
bility maintaining RNA:DNA hybrids in  vivo. As the 
analyses of repetitive sequences suggested enrichment of 
purine-rich RNA in these RNA:DNA hybrids, this finding 
Fig. 2 Mapping of RNA:DNA hybrids within the ribosomal DNA repeat unit. The upper panel shows the results of RDIP-seq (gray) and RNA-seq (red), 
with genomic annotations and results of ChIP-seq analysis in K562 cells [55] plotted below. RDIP-seq and RNA-seq data are both represented using 
a smoothed plot showing the number of reads aligned to each basepair of the repeating unit, while the ChIP-seq data signal intensity represents 
the mean value of non-overlapping 50 bp windows. RDIP-seq values were normalized by subtracting the frequencies of aligned reads of the input 
sample in each window. We find that RNA:DNA hybrids co-localize with the rRNA transcripts, but that there are also RDIP-seq peaks of comparable 
magnitude in the intergenic spacer (IGS) where no transcriptional activity is apparent from RNA-seq. The RNA:DNA hybrids in the IGS are upstream 
of the promoter region and flank the upstream candidate cis-regulatory sequence where there is H3K4 methylation and acetylation of H3K9 and 
H3K27
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was explored more fully, testing for and finding from 
the genome-wide data a strong intramolecular skew-
ing towards GA:CT enrichment (Fig.  4a). To test glob-
ally whether this purine (GA) enrichment was present 
on the RNA-containing strand, the directional sequence 
information was used to examine nucleotide skewing 
on each strand at RNA:DNA hybrids, confirming the 
RNA-derived sequence to be strongly purine-enriched 
(Fig.  4b). The 10  % of peaks with the least tendency 
towards having the RNA enriched on one strand were 
removed from further analyses as being likely to over-
represent experimental noise.
Relationship of RNA:DNA hybrids to local transcription
As some RNA:DNA hybrids have been found to have 
transcriptional termination properties [56, 57], it was 
tested whether the RDIP directional sequencing allowed 
the observation of the an orientation bias within genes. 
This tendency has been observed for transposable ele-
ments, which are believed to have different effects on 
gene function depending on their insertion orientation 
in gene bodies [58, 59]. The nucleotide skewing within 
each peak was visualized, revealing the purine-enriched 
component to be displaced 5′ from the mid-point of the 
peak (Additional file  1: Figure S3), which is consistent 
with the RDIP protocol using the RNA component of 
the RNA:DNA hybrid to prime second strand synthesis, 
proceeding unidirectionally 3′ and relatively under-rep-
resenting the region 5′ to the RNA. This observation is 
independently supportive of the RNA component of the 
RNA:DNA hybrid being purine-enriched. There was a 
modest orientation bias against purine-rich sequences in 
the same orientation as the gene (Additional file  1: Fig-
ure S3b), indicating that most but not all genes tolerate 
an RNA:DNA hybrid with the RNA on the transcribed 
strand.
To explore the relationship between RNA:DNA hybrid 
formation and transcription further, the proportions 
of genes with peaks were tested for transcription states 
from the RNA-seq data, finding that most transcribed 
RefSeq genes do not contain RNA:DNA hybrids but 
that the transcribed genes have a higher frequency of 
RNA:DNA hybrids than non-transcribed genes (7.75  % 
compared with 6.09  %; Fig.  5a). The locations of these 
RNA:DNA hybrids within genes was defined using a 
metaplot, identifying the first ~ 1.5 kb downstream from 
Fig. 3 Genomic distribution of RNA:DNA hybrids. In panel a we show that the proportion of reads mapping to rDNA is 2 %, and break down the 
remaining 98 % by genomic context, showing the majority of RNA:DNA hybrids (called as peaks using ChIP-seq analytical approaches) to be located 
in intergenic regions. To understand these RNA:DNA hybrid distributions, we calculated observed/expected ratios based on nucleotide occupancy 
of genomic features, and performed permutation analyses testing for the likelihood of randomized intersection (b), the results of which are shown 
in Additional file 2: Table S1. We found depletion of RNA:DNA hybrids at RefSeq gene bodies, intergenic regions, and SINE and DNA transposable 
elements but significant enrichment at promoters and CpG islands, and a number of purine-rich repetitive sequences
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Fig. 4 Nucleotide skewing analyses. In panel a we plot the skewing within a strand of A compared to T (x axis) or G compared to C (y axis) in the 
RNA:DNA hybrid peaks genome-wide. We find that the peaks are strongly over-represented for purine (G+A) and pyrimidine (C+T) skewing. As 
our sequencing approach allowed us to identify the RNA and DNA-derived strands separately in the RNA:DNA hybrid, in b we proceeded to test 
whether there was a relationship between skewing (based on the number of G+A divided by the total number of nucleotides) and each type of 
nucleic acid-derived sequence, finding a clear enrichment for purine skewing on the RNA-derived strand
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Fig. 5 Transcriptional relationships of RNA:DNA hybrids. In a the proportion of RNA:DNA hybrid peaks in transcribed genes is shown to be higher 
than in non-transcribed genes, but that the majority of genes do not contain RNA:DNA hybrids. In b a metaplot of RNA:DNA hybrid peaks is shown, 
illustrating the number of peaks intersecting with 100 bp windows, with the RNA of the hybrid on the transcribed strand of the gene (red) or the 
opposite strand (blue). This revealed an enrichment of the RNA-derived sequence on the transcribed strand in the first ~1.5 kb downstream from 
the transcription start site (TSS). A depletion of RNA:DNA hybrids is found at the transcription end site (TES). In c we show that the region immedi-
ately downstream from the TSS is purine-skewed, represented by skewing values of 100 bp windows averaged for all genes, but that this is to the 
same degree in genes that form RNA:DNA hybrids (blue) as those genes that do not form these structures (red). In d a metaplot of RefSeq genes 
(left) shows that the transcription level of genes (as measured by RNA-seq) is positively associated with the number of RN:DNA hybrids intersecting 
with 100 bp windows immediately downstream of the TSS. This reflects only modest increases in the small proportions of genes forming peaks 
(right), though found to be a significant relationship using a proportions test
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the transcription start site (TSS) as the region most con-
sistently enriched (Fig.  5b). This region is also found to 
be modestly enriched in purine skewing for genes with 
and without RNA:DNA hybrids (Fig.  5c). Surprisingly, 
given the transcriptional termination properties attrib-
uted to RNA:DNA hybrids [56, 57], the transcriptional 
end site is notable for a slight depletion of these struc-
tures (Fig. 5b). The information from lncRNAs also sug-
gests a modest enrichment for RNA:DNA hybrids in the 
immediate vicinity of the TSS (Additional file  1: Figure 
S4). The local generation of RNA:DNA hybrids has pre-
viously been described to be associated with transcrip-
tion of the region [14, 22], so the genes were stratified by 
expression level, finding that the proximal 1.5 kb region 
downstream from the TSS showed an increase in peaks 
associated with increasing quantiles of gene expression 
states (Fig. 5d). The conclusion is that transcriptional lev-
els have effects on the likelihood of forming RNA:DNA 
hybrids, and that local purine enrichment may increase 
the tendency of these structures to be formed in the 
~1.5  kb immediately downstream of the TSS in a small 
subset of genes.
As RNA-seq measures the steady state of RNA in the 
cell, and does not necessarily reflect active transcrip-
tion, we added an analysis of global run-on sequencing 
(GRO-seq) data generated previously for IMR-90 cells 
[60]. We found 24,875 RNA:DNA hybrids in these cells 
to map to RefSeq genes, 24,174 to active genes of which 
23,717 had evidence for transcription from GRO-seq 
data. Interestingly, of the 788 RNA:DNA hybrids map-
ping to genes with no evidence for transcriptional activ-
ity from our RNA-seq data, 733 mapped to loci where 
GRO-seq indicated local transcription. Exploration of the 
57,308 RNA:DNA hybrids mapping to intergenic regions 
revealed 11,825 to map to loci where GRO-seq indicated 
transcription. These data suggested GRO-seq to be a 
more sensitive indicator of transcription than RNA-seq 
or genomic context, prompting us to explore how many 
of the RNA:DNA hybrids mapped to loci where GRO-seq 
indicated transcription, finding evidence for transcrip-
tion at 27,352 (47.7 %) of the RNA:DNA hybrids.
Relationship of RNA:DNA hybrids to regulators 
of transcription
To begin to infer any transcriptional regulatory func-
tion of the RNA:DNA hybrids from their genomic loca-
tions, studies were performed correlating RNA:DNA 
hybrid locations with enrichment or depletion for other 
chromatin and transcriptional regulators directly over-
lapping the RNA:DNA hybrids. Using IMR-90 bisul-
phite sequencing data from the Roadmap Epigenomics 
Project (accession number NA000020923.1), a modest 
decrease in DNA methylation within RNA:DNA hybrids 
was found compared with genome-wide levels, a find-
ing which is consistent with the hypomethylation of 
DNA previously observed for RNA:DNA hybrids at CpG 
islands [16] (Additional file 1: Figure S5a). In vitro stud-
ies have shown RNA:DNA hybrids to be refractory to the 
formation of nucleosomal structures [17], a finding sup-
ported by the observation that 7.46  % of all RNA:DNA 
hybrids overlap DNase hypersensitive sites, represent-
ing a significant association genome-wide (Additional 
file  1: Figure S5b, c). We also tested whether there may 
be unrecognized transcription at enhancer RNAs [61, 
62] at sites of formation of RNA:DNA hybrids. We found 
that of the 57,308 RNA:DNA hybrids, 4277 (7.46  %) 
map to DNase hypersensitive sites, of which 3560 have 
the H3K27ac modification, most of which (3434) also 
have the H3K4me1 modification. Of these H3K27ac/
H3K4me1 DNase hypersensitive sites with RNA:DNA 
hybrids, 2154 have evidence for transcription from GRO-
seq. As enhancer RNAs are inherently unstable [63], it 
is possible that transcription is actually occurring at a 
higher proportion of these loci that the GRO-seq data 
would indicate, potentially linking transcription with 
RNA:DNA hybrid formation at as many as the 7.46  % 
located at DNase hypersensitive sites. A motif analysis of 
RNA:DNA hybrid-forming loci genome-wide revealed an 
enriched polypurine (GGAA)n sequence, which has been 
associated with binding by the FLI1 transcription factor 
[64] (Additional file 1: Figure S6a).
A notable macro-scale organization of RNA:DNA 
hybrids was apparent in the human genome, with regions 
of dense and sparse RNA:DNA hybrid formation (exam-
ple shown in Additional file  1: Figure S6b). Using pub-
licly-available ChIP-seq data from the IMR-90 cell line, 
it was possible to ask whether RNA:DNA hybrids in the 
human genome occur in regions of distinctive regulatory 
characteristics. We have previously noted that there is 
extensive inter-correlation of genomic features [65], mak-
ing it difficult to discriminate specific associations when 
there are multiple correlating genomic variables. In order 
to explore the transcriptional and regulatory context of 
RNA:DNA hybrid peaks, regression models were fitted 
to the data, regularized using the least absolute shrink-
age and selection operator (LASSO; [66]) with the peak 
density as the response variable. Least angle regression 
(LARS; [67]) was used, progressively adding covariates 
to the model and testing the significance of each added 
predictor using the covariance test statistic proposed 
by Lockhart et al. [68]. The results of this procedure are 
shown in Fig. 6. The first covariate to enter the model as 
significantly enriched in co-localization with RNA:DNA 
hybrids in 500  kb windows is the repressive histone 
mark, H3 lysine 27 trimethylation (H3K27me3), followed 
by CpG islands, L1 LINE retroelements and a further 
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repressive histone mark, H3K9me3. The first eight covar-
iates to enter the model all gave significant values of the 
covariance test statistic.
Local chromatin organizational studies using mass 
spectrometry
Finally, characterization of chromatin located at 
RNA:DNA hybrids was performed to identify the pro-
teins enriched at these loci. Chromatin from HEK 293T 
cells was sonicated and a fraction immunoprecipitated 
with the S9.6 antibody, eluting the protein complexes 
using RNA:DNA hybrid oligonucleotides, and identifying 
local proteins through mass spectrometry (Fig. 7a). These 
results and Western blotting validation of candidate pro-
teins of interest are shown in Fig. 7b and Additional file 2: 
Table S2. A number of different specific proteins plausibly 
associated with RNA:DNA hybrids were identified. RNA 
helicase A (encoded by DHX9) is a protein known to be 
involved in resolving RNA:DNA hybrids [69] and is a nec-
essary partner for FLI1 in tumourigenesis [70], while DNA 
binding protein B (YBX1) is known to bind to ssDNA [71] 
which should be part of R-loops formed at these loci. ILF2 
and ILF3 are also found in the chromatin at RNA:DNA 
hybrids. These are transcription factors known to recog-
nize a purine-rich motif [72], with our results raising the 
possibility that their binding may depend on the target 
nucleic acid existing in an RNA:DNA conformation.
The presence in local chromatin of RNA helicases 
and topoisomerases is consistent with prior reports that 
these enzymes are involved in the removal of RNA:DNA 
hybrids [26, 42]. The question arose whether the IMR-
90 and HEK 293T cells express the genes encoding the 
broader group of proteins implicated in removal of 
RNA:DNA hybrids in vivo. Using the RNA-seq data, nine 
Fig. 6 Macro-scale genomic associations of RNA:DNA hybrids. We used a least absolute shrinkage and selection operator (LASSO) adaptive regres-
sion approach to explore the association of genomic sequence features with RNA:DNA hybrid density in 500 kb windows. The figure shows the 
order in which covariates enter the model as the constraint on the sum of the regression coefficients (x axis) is progressively relaxed from 0 to its 
maximum value (corresponding to the ordinary least squares regression vector)
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of these genes were categorized into quartiles of expres-
sion, finding that all of the genes were expressed at high 
levels (Additional file  1: Figure S7). The presence of the 
RNA:DNA hybrids in these cells is therefore in spite of 
robust levels of expression of genes encoding proteins 
that should actively remove them.
Fig. 7 Chromatin organizational studies at RNA:DNA hybrids using mass spectrometry. In panel a we show the experimental approach used for 
these proteomic studies. In b the altered pattern of enriched proteins compared with the input sample is seen using gel electrophoresis, and the 
results of Western blots confirming the enrichment of specific candidate proteins identified by mass spectrometry (ILF2, ILF3, hnRNP C1/C2), with 
SP1 and SP3 as controls known to bind to G-skewed DNA motifs
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Discussion
Mapping RNA:DNA hybrids in human cells has allowed 
new insights into the properties of these non-canonical 
nucleic acid structures. We confirm through subcel-
lular localization studies prior observations that the 
ribosomal DNA harbors these structures [16] (Fig.  1). 
Additionally, we expand on findings in yeast [28] by 
mapping RNA:DNA hybrid locations within the human 
rDNA repeating unit, revealing these structures to be 
formed not only at the expressed rDNA gene but also in 
the intergenic spacer sequence (Fig.  2). The signal from 
this repetitive sequence is necessarily composed of all 
rDNA repeat units in the genome, so we cannot distin-
guish events occurring within individual alleles, but we 
can make several inferences. Firstly, that the enrichment 
of RNA:DNA hybrids within the rDNA repeat unit is not 
uniform but is enriched at two types of loci, the exons 
of the rRNA genes and the intergenic spacer sequence 
where they spare candidate cis-regulatory loci (Fig.  2). 
The mapping of RNA:DNA hybrids to the rDNA gene 
exons is an interesting finding as it implies that the RNA 
associating with the rDNA is already spliced and not the 
primary transcript through the region. This is less sup-
portive of a co-transcriptional model for RNA:DNA 
hybrid formation [29, 30] and more indicative of rRNA 
acting in trans to generate these structures, as has been 
found for RNA:DNA hybrids in yeast [24].
The mapping of reads to the rDNA repeat was con-
sistent with the imaging data indicating the presence 
of RNA:DNA hybrids in nucleoli (Fig.  1), allowing us 
to proceed with confidence to assess the distribution 
of the majority of the reads elsewhere in the genome. 
The first observation was that the RNA:DNA hybrids 
were not enriched in gene bodies relative to intergenic 
sequences (Fig. 3a, b), again failing to support their pres-
ence being solely a function of recognized transcrip-
tion. Furthermore, the rRNA model would suggest that 
spliced mRNAs might associate in trans with their genes 
of origin, but this is not reflected by over-representation 
of RNA:DNA hybrids in RefSeq genes (Fig.  3b). Instead 
we observe that a small proportion of genes have peaks 
within their bodies (Fig.  5a), with a significantly higher 
proportion of expressed genes than silent genes contain-
ing RNA:DNA hybrids (Fig.  5d). These tend to form in 
the ~1.5 kb immediately downstream of the transcription 
start site, where they are influenced by the level of tran-
scription (Fig.  5d) but can be found even in genes that 
are not measurably expressed by RNA-seq (Fig.  5a, d), 
and are overall depleted in RefSeq gene bodies (Fig. 3b). 
Analysis of GRO-seq data from IMR-90 cells [60] reveals 
evidence for transcriptional activity at genes categorized 
as silent by RNA-seq, and at loci of open chromatin in 
the genome, which should include sites of transcription 
of enhancer RNAs [61, 62]. Overall, however, even these 
sensitive indicators of active transcription only account 
for a subset of RNA:DNA hybrids in the genome, indi-
cating that transcription through a locus is therefore only 
moderately influential in generating these structures.
Adding to the tendency of the proximal 1.5 kb to form 
RNA:DNA hybrids is the enrichment at this location 
genome-wide for purine-skewed DNA in the transcrip-
tional orientation of the gene (Fig.  5c). We first noticed 
that purine enrichment may be a property of RNA:DNA 
hybrids in vivo when we found a strong enrichment for 
repetitive sequences composed of polypurines in our 
RepeatMasker analysis (Fig. 3b). We confirm the purine 
skewing to be a general property of these sequences 
(Fig. 4; Additional file 1: Figure S3), which extends prior 
observations that suggested isolated G density [14] or 
GC [19] skewing, to be characteristic of these loci. As 
purine-rich RNA binds to complementary pyrimidine-
rich DNA with greater affinity than the same purine-rich 
DNA sequence in vitro [12, 20], this is likely to be a factor 
in the ability of the RNA to maintain displacement of the 
ssDNA in the R-loop structure.
While transcriptional termination has been described 
to be a property of RNA:DNA hybrids [56] (reviewed 
in [11]), we observe that RNA:DNA hybrids are not 
enriched at the annotated ends of RefSeq genes and are, 
in fact, relatively depleted (Fig.  5b). However, we see a 
small orientation bias in RefSeq genes, with a shift away 
from RNA:DNA hybrids with the RNA in the same ori-
entation as transcription (Additional file  1: Figure S3). 
We interpret this to indicate that a subset of RNA:DNA 
hybrids may cause transcriptional disruption effects, but 
that it is not a universal property throughout the genome.
We can infer some likely functional properties of 
RNA:DNA hybrids by genomic co-localization and pro-
teomic approaches. The genomic co-localization studies 
were both immediately at the RNA:DNA hybrid loca-
tion and more broadly in their flanking regions, the latter 
prompted by what appeared to be higher-scale organi-
zation of the distribution of these loci (Additional file 1: 
Figure S6b) and by prior studies in yeast [34]. The imme-
diate local features included DNase hypersensitivity 
(Additional file 1: Figure S5b, c), which is consistent with 
prior in vitro published findings that nucleosomes do not 
readily form on these structures [17]. The tendency of 
RNA:DNA hybrids to be resistant to acquisition of DNA 
methylation [16] finds some support from our data, but 
the modest degree of relative hypomethylation indicates 
that the effects occur at only a small subset of loci. In 
the regional analysis of the co-localization of RNA:DNA 
hybrids and genomic sequence features within 500  kb 
windows of the genome, the enrichment found for CpG 
islands was not surprising given our observations that 
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promoter-proximal sequences are enriched in RNA:DNA 
hybrids (Fig.  3b). However, the enrichment in the same 
broader regions for the repressive H3K27me3 and 
H3K9me3 marks was unexpected for structures with the 
possibility of being co-transcriptionally generated. We 
interpret this to indicate one of the following three pos-
sibilities: that these regions are more transcribed than 
we can appreciate using the data available to us, allowing 
co-transcriptional formation of RNA:DNA hybrids, or 
that RNA forming RNA:DNA hybrids in trans is better 
able to target these regions, or that these structures are 
more stable in the context of repressive heterochromatin, 
with a causal model prompted by observations in fission 
yeast [34] that would involve the RNA:DNA hybrids hav-
ing a mechanistic role to induce the regional repressive 
organization.
The proteins revealed by the proteomic studies were 
consistent with the local presence of RNA:DNA hybrids 
and R-loops (Fig. 7; Additional file 2: Table S2), including 
RNA helicase (DHX9) and single-stranded DNA binding 
properties. We were especially intrigued by the presence 
of the ILF2 and ILF3 components of the Nuclear Factor 
of Activated T-cells (NF-AT) transcription factor, which 
is required for T cell expression of interleukin 2 and rep-
resents a target of the immunosuppressive Cyclosporin 
A and FK506 drugs [73]. ILF2 (NF45) and ILF3 (NF90) 
are characterized by their binding to polypurine-rich 
interleukin gene enhancers [72], and are described to 
have the property of being able to bind to dsRNA in vitro 
[74]. This property, when combined with our finding of 
enrichment in chromatin at RNA:DNA hybrids, suggests 
that the selective binding of NF-AT at specific genomic 
locations may be dependent upon those sites being in 
an RNA:DNA hybrid conformation, which is structur-
ally more similar to A-form dsRNA than B-form dsDNA 
[12]. The sequence motif (GGAA)n that we found to be 
enriched at RNA:DNA hybrids (Additional file 1: Figure 
S6a) closely resembles that of the binding site for the 
FLI1 transcription factor [75]. FLI1 is a master regula-
tor of hematopoiesis [76] in the ETS family, and has been 
causally implicated in pediatric Ewing’s sarcoma [77]. The 
oncogenic effect of FLI1 (as a fusion protein with EWS) 
is enhanced by RNA helicase A [70] which it appears 
to inhibit [78], an interaction that can in turn be inhib-
ited by small molecules with therapeutic potential [79]. 
Expression of EWS-FLI1 induces chromatin opening at 
sequences with the (GGAA)n motif [80]. The combina-
tion of the findings of binding to a polypurine-rich motif 
and interaction with RNA helicase A combine to suggest 
that FLI1 may also bind to an RNA:DNA nucleic acid 
conformation.
The model for RNA:DNA hybrid physiology that 
results from our studies indicates that they form as a 
result of an equilibrium between formation, stability 
and removal, with increased transcription having only a 
modest influence for the subset we believe to be formed 
co-transcriptionally. Once formed, those at purine-
skewed loci are likely to be more stable thermodynami-
cally, resisting the presence of enzymes like RNA helicase 
A in the local chromatin and the robust expression of 
genes encoding proteins that remove RNA:DNA hybrids 
(Additional file 1: Figure S7), reflecting how these struc-
tures persist despite active processes dedicated to their 
removal. The RNA:DNA hybrids form DNase hypersen-
sitive structures which may facilitate or reflect binding 
of transcription factors with preferences for either the 
A/B form RNA:DNA duplex or the ssDNA in the R loop, 
and exist in large scale domains of repressed chromatin, 
with which their causal relationship is uncertain. We pro-
pose that the weight of evidence supports many of the 
RNA:DNA hybrids being formed in trans, by RNA tran-
scripts originating from regions of the genome other than 
the location of the RNA:DNA hybrid itself. The ability of 
RNA to invade a double stranded DNA molecule in trans 
is being strikingly highlighted at present by CRISPR/Cas 
technology, which creates an RNA:DNA hybrid as part 
of an R-loop [81]. We find little evidence for the major-
ity of the RNA:DNA hybrids in  vivo to be located at 
recognizably transcribed sequences. More persuasively 
supporting a trans hypothesis is the finding that the 
RNA:DNA hybrids in the rDNA repeat unit map to pro-
cessed rather than primary rRNA transcripts. The sim-
plicity of the polypurine-skewed sequences at RNA:DNA 
hybrids potentially allows a limited number of transcripts 
to target a large number of loci. The nuclear-retained 
polypurine-rich RNAs found in mammalian cells repre-
sent a type of non-coding RNA of unclear function [82] 
that could mediate such trans effects in vivo. Overall, it 
appears that there are numerous influences upon physi-
ological RNA:DNA hybrid formation, the dissection of 
which will be essential if we are to understand the roles 
ascribed to them in disease states [83].
Conclusions
A systematic analysis of RNA:DNA hybrids in human 
cells reveals their presence throughout the genome, 
including in the ribosomal DNA repeat unit, cumulatively 
representing millions of base pairs of DNA. The results 
help to resolve a number of conflicting theories about 
the formation of RNA:DNA hybrids, with only small 
influences of local transcription found, and evidence 
indicative of their formation in trans. Their sequence 
characteristics are clearly shown to be defined by purine 
enrichment for the RNA component of the hybrid, sup-
porting a thermodynamic characteristic of RNA:DNA 
hybrids that should favor their stability. Functionally, we 
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find evidence linking the presence of these structures to 
local DNA methylation and local and regional chromatin 
organizational states, with proteomic studies revealing 
the presence of transcription factors that may be bind-
ing preferentially to the RNA:DNA conformation. The 
contribution of non-canonical nucleic acid structures in 
transcriptional regulation is underexplored but warrants 
further investigation, adding a new layer of information 




The S9.6 antibody-producing hybridoma line was pur-
chased from ATCC (HB08730), and the hybridoma line 
was grown in Integra Flasks by our institution’s mono-
clonal antibody core facility in serum-free medium. The 
S9.6 antibody was then purified by the macromolecular 
therapeutics core facility using a Protein-G column and 
size exclusion. The antibody was validated using an elec-
trophoretic mobility shift assay (EMSA) and southwest-
ern blotting to test for specificity to RNA:DNA hybrid 
oligonucleotides. A full description of these experiments 
is provided in the Additional file 1: Supplemental experi-
mental procedures.
Immunofluorescence
HEK 293T cells were fixed in 4 % paraformaldehyde for 
10 min at room temperature, and then permeabilized for 
10 min with 0.5  % Triton-X-100. The cells were immu-
nostained with anti-S9.6 antibody and anti-Fibrillarin 
antibody (Cell Signaling) for 1  h, washed three times 
with phosphate buffered saline (PBS), and incubated with 
Alexa Fluor 488-labeled anti-mouse IgG antibody and 
Alexa Fluor 568 labeled anti-rabbit IgG antibody (Invit-
rogen) for 30 min at room temperature. Finally, cells were 
mounted in mounting solution ProLong Gold with DAPI 
(Invitrogen).
FISH
Fluorescence in situ hybridization (FISH) was performed 
using our previously published approach [84]. For the 
experiment described, 2  µg of DNA from the Illumina 
RDIP-seq library were labeled by nick translation using 
spectrum orange-dUTP (Invitrogen, Carlsbad, CA). A 
locus-specific BAC clone (9p TelVysion probe #05J03-
009) mapping to chromosome 9 was labeled in green 
using Spectrum Green (Vysis, Abbott Molecular, Des 
Plaines, IL). Both probes were hybridized to 46, XY con-
trol metaphases. The slides were denatured with 50  % 
formaldehyde/2× SSC at 80 °C for 1.5 min and then dehy-
drated with serial ethanol washing steps (ice cold 70, 90, 
and 100 % for 3 min each). The probes were denaturated 
in the hybridization solution (50  % dextran sulfate/2× 
SSC) at 85 °C for 5 min, applied to the slides, and incu-
bated overnight at 37  °C in a humidified chamber. The 
slides were then washed 3 times for 5  min with 50  % 
formamide/2× SSC, 1× SSC and 4× SSC/0.1 % Tween. 
Slides were dehydrated with serial ethanol washing steps 
(see above) and mounted with ProLong Gold antifade 
reagent with DAPI (Invitrogen, Carlsbad, CA, USA) for 
imaging. Image acquisition is described in Additional 
file 1: Supplemental experimental procedures.
RNA:DNA hybrid immunoprecipitation (RDIP)
The cell culture conditions for IMR-90 and HEK 293T 
cells are described in the Additional file  1: Supplemen-
tal experimental procedures. Whole cell nucleic acid was 
isolated from HEK 293T cells and IMR-90 cells through 
a modified salting out extraction protocol [85]. Nucleic 
acid was sonicated to an average size of 400–600  bp 
using the Covaris sonicator. The fragmented nucleic 
acid was then treated with RNase I (Ambion AM2294) 
to remove any ssRNA from the sample, phenol/chloro-
form purified and re-suspended in EB buffer. Part of the 
nucleic acid sample was set aside as an untreated input 
sample for comparative sequencing. Three micrograms 
of nucleic acid sample was then incubated overnight 
with the S9.6 antibody, following which the RNA:DNA 
hybrids were enriched by immunomagnetic precipitation 
using Dynabeads (M-280 Sheep anti-mouse IgG). The 
sample was then extracted through phenol/chloroform 
purification, precipitated in the presence of glycogen and 
re-suspended in EB buffer. A complete detailed protocol 
is available in the Additional file 1: Supplemental experi-
mental procedures. Enrichment of predicted peaks in 
the RDIP product was validated using quantitative PCR 
(Quanta PerfeCTa SYBR Green Fastmix). The primer 
sequences used are provided in Additional file  2: Table 
S3.
Directional RDIP‑seq
Using RDIP and input material, directional RDIP-seq 
libraries were prepared using elements of a directional 
RNA-seq protocol modified from a previously published 
approach [49]. Starting the library preparation at the 
second strand synthesis step, the RNA of the RNA:DNA 
hybrid was nicked using RNase H treatment to serve as a 
primer for the DNA polymerase. The second strand was 
formed while incorporating dUTP to allow for directional 
sequencing and the identification of the RNA strand 
of the RNA:DNA hybrid. Next, the ends of fragments 
were repaired, adenosine tails added, and Illumina Tru-
Seq strand-specific adaptors ligated (adaptor sequences 
in Additional file  2: Table S4). UNG treatment was uti-
lized to degrade the dUTP-containing RNA strand of the 
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RNA:DNA hybrid, and barcoded PCR primers were used 
to amplify the library while maintaining directionality. 
The complete RDIP-seq protocol is available in the Addi-
tional file 1: Supplemental experimental procedures.
Prior to sequencing, the libraries were analyzed for 
quality of preparation using an Agilent Bioanalyzer high-
sensitivity chip. Libraries were multiplexed and combined 
for sequencing using Illumina HiSeq 2500 150 bp paired-
end sequencing in our institutional Epigenomics Shared 
Facility. FASTQ files were generated through the Illumina 
CASAVA pipeline (v1.8). Sequencing reads were then 
run through the Wasp System (WASP v3.1.5 rev. 6632) 
hosted pipeline for primary data processing, as follows. 
The reads were aligned to the hg19 reference genome 
using Bowtie (v0.12.7), using non-default parameters 
of –tryhard (increasing the number of attempts bowtie 
uses to find an alignment and number of backtracks), -I 
50 (the minimum insert size in basepairs for valid paired-
end alignments) and -X 650 (the maximum insert size for 
valid paired-end alignments). Alignments were gener-
ated in SAM format, which were then transformed into 
BAM files using Samtools (version 0.1.8). The aligned 
sequences in BAM format had PCR duplicates removed, 
and peaks were called based on input and IP files using 
MACS v1.4.2 [86]. RDIP-seq peaks for IMR-90 cells and 
two datasets for HEK 293T cells were then analyzed 
using the program CHANCE for quality of immunopre-
cipitation [87]. Based on the results of CHANCE, we 
discarded one of the HEK 293T datasets and continued 
on with one set of peaks for each cell line. All peaks con-
taining “N” nucleotides were discarded. Custom code 
and parameters for this analysis can be found on our 
GitHub resource in the file “Peak Calling”. Motif analysis 
of RNA:DNA hybrid peaks is described in the Additional 
file 1: Supplemental experimental procedures.
R‑loop validation through non‑denaturing bisulphite 
conversion
RDIP-seq peaks were validated through non-denaturing 
bisulphite conversion. Whole cell nucleic acid was iso-
lated from HEK 293T cells through a modified salting out 
extraction protocol as outlined in the Additional file  1: 
Supplemental experimental procedures. Nucleic acid was 
digested with EcoRV-HF. Non-denaturing bisulphite treat-
ment was performed according to a previously published 
protocol [50]. Regions of interest were amplified through 
PCR after denaturing or non-denaturing bisulphite treat-
ment using primers to converted or unconverted DNA. 
The PCR product was purified, cloned using a TOPO-TA 
cloning kit (Life Technologies) and sequenced. The primer 
sequences used in non-denaturing bisulphite validation for 
this study are provided in Additional file 2: Table S5.
Directional RDIP‑seq strandedness analysis
Due to using directional sequencing through the incor-
poration of dUTP, we were able to determine the RNA-
derived sequence of the RNA:DNA hybrids. To do this, 
we used the BAM flag information describing our aligned 
sequences (http://broadinstitute.github.io/picard/). 
The second read in the pair, representing the sequence 
derived from the RNA strand following degradation 
using UNG of the dUTP-incorporated complementary 
strand, has the bit flag identifiers of 163 or 147, indicat-
ing that it maps to the top or bottom strand of the refer-
ence genome, respectively. By measuring the number of 
RNA reads aligned to the top or bottom reference strand 
for each peak, we could assign each RDIP-seq peak a 
“strandedness” value, with +1 being all RNA-derived 
reads aligned to the top strand and −1 all RNA-derived 
reads aligned to the bottom strand. We removed the 
small minority (10 %) of peaks with intermediate values 
of strandedness to decrease what we presumed to be 
experimental noise in our data set. Custom code for this 
analysis can be found on our GitHub resource in the file 
“Determining RNA Strand and Minus10 files”.
RNA‑seq of HEK 293T cells and IMR‑90 cells
RNA was isolated from HEK 293T and IMR-90 cells 
using TRIzol extraction. Four biological replicates from 
each cell line were DNase treated, and Ribo-Zero rRNA 
removal (Ribo-Zero, Epicentre) was utilized for three of 
the four RNA samples, leaving a non-Ribo-Zero depleted 
sample for rRNA expression analysis. RNA-seq librar-
ies were prepared using a directional RNA-seq proto-
col modified from a prior published approach [49] and 
detailed in the Additional file  1: Supplemental experi-
mental procedures, Directional whole transcriptome 
sequencing protocol. Prior to sequencing, the libraries 
were assessed for quality using an Agilent Bioanalyzer 
high-sensitivity chip. The samples were multiplexed and 
sequenced using 100  bp single-end read sequencing on 
the Illumina HiSeq  2500 in our institutional Epigenom-
ics Shared Facility. The TruSeq adaptor sequences used in 
this assay are provided in Additional file 2: Table S6.
After sequencing, FASTQ file generation was com-
pleted using the Illumina CASAVA pipeline (v1.8). Post-
sequencing analysis was performed using the WASP 
pipeline (v3.1.5 rev. 6632), involving read alignment 
using gsnap (2012-07-20), with htseq (v0.5.3p3) used to 
determine read quantitation. Biological replicates were 
normalized using DESeq (Bioconductor) and RefSeq 
gene identifiers were assigned using biomaRt. Only gene 
expression assigned a RefSeq identifier was used for fur-
ther analysis. Custom code for this analysis can be found 
on our GitHub resource under the file “RNAseq analysis”.
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Ribosomal DNA analysis
In order to align our RDIP-seq reads to the rDNA repeat-
ing unit, we used the alignment approach of Zentner 
and colleagues [55]. We added the rDNA repeating unit 
FASTA file (gi|555853|gb|U13369.1|HSU13369) to the 
start of the hg19 chromosome 13, replacing the telomeric 
“N” nucleotides. Duplicate reads were removed from the 
IMR-90 RDIP-seq and input FASTQ files using a custom 
perl script provided by Zentner and colleagues [55], and 
the remaining reads were aligned to the hg19+rDNA 
genome file using Bowtie. Wiggle tracks were then cre-
ated using FSeq, and counts representative of the reads 
aligned to the rDNA portion of chromosome 13 were iso-
lated. The RDIP-seq wiggle track values were normalized 
by subtracting the input values from the RDIP values. 
The same pipeline was used to align the IMR-90 RNA-
seq samples that did not have prior Ribo-Zero depletion 
to the rDNA sequence. Processed histone mark datasets 
from K562 cells for rDNA were provided by Zentner 
and colleagues [55], and averaged across 50 bp windows 
across the rDNA repeating unit. Custom code for this 
analysis can be found on our GitHub resource under the 
file “Fig.  2—rDNA figure with Zentner histone marks” 
and the custom perl script under “Zentner removeDups-
FromFASTQ Perl Script”.
Regression models of RNA:DNA hybrid peak density
We used LASSO regularized linear regression to explore 
the relationship between the density of RNA:DNA hybrid 
peaks in 500 kb windows and genomic features associated 
with transcription and regulation. LASSO regression fits 
a linear model subject to a constraint on the sum of the 
regression coefficients [66]. The LARS algorithm, imple-
mented in the LARS R package, was applied to determine 
the Lasso path. This algorithm provides the optimal val-
ues of the regression coefficients as the constraint on 
the sum of the coefficients is progressively relaxed [67]. 
Tight constraint on the sum of the coefficients enforces 
sparseness on the model with the number of covariates 
in the model increasing as this constraint is relaxed. The 
covariance test statistic [68], implemented in the covTest 
R package, was used to test the significance of each addi-
tional covariate when it enters the model.
Co‑immunoprecipitation of RNA:DNA hybrid binding 
proteins (CoIP)
Native chromatin was isolated using a sucrose gradi-
ent from HEK 293T cells. Chromatin was incubated 
overnight with S9.6 antibody or a non-specific con-
trol antibody (β-actin, Sigma A5441), following which 
immunoprecipitation was performed on each sample 
using immunomagnetic precipitation (Dynabeads M-280 
Sheep anti-mouse IgG). RNA:DNA hybrid-binding 
protein complexes were then eluted using RNA:DNA 
hybrid oligonucleotides, with DNA:DNA oligonucleo-
tides as a control. The oligonucleotide sequences used 
in this assay are provided in Additional file  2: Table S7. 
The resulting enriched proteins were run on a 12 % poly-
acrylamide gel, stained with GelCode Blue (Life Technol-
ogies 24594) and tested using Mass Spectrometry (MS). 
Proteins which were considered to bind specifically to 
RNA:DNA hybrids were defined as those only present in 
the S9.6 immunoprecipitated sample and eluted with the 
RNA:DNA oligonucleotides, removing any proteins also 
present in the control samples (those isolated with the 
β-actin antibody, and with the S9.6 antibody eluted with 
the DNA:DNA oligonucleotides). This analysis was per-
formed using Scaffold3 proteome software [88]. Peptide 
counts were assigned to each protein identified through 
mass spectrometry by measuring the quantity of the 
identified peptides by their spectra, and filtered by those 
peptides that also occurred in negative control experi-
mental samples. Candidate proteins identified by mass 
spectrometry were then validated using Western blotting 
using the antibodies described in Additional file 2: Table 
S8.
Custom code
Analysis of RDIP-seq, RNA-seq, and code for all fig-
ures are included and annotated at: https://github.com/
GreallyLab/Nadel-et-al.-2015.
Data access
The data generated are all available through the Gene 
Expression Omnibus, accession number GSE68953 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68953).
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